Research into obsessive-compulsive disorder shows antibodies could provide new treatment

  • Fulvio D'Acquisto (Contributor)

Activity: Public engagement and outreach › Media Article or Participation

Description

Scientists at Queen Mary University of London and the University of Roehampton, London, have discovered that patients suffering from obsessive compulsive disorder (OCD) have increased levels of a protein called Immuno-moodulin (Imood) in their lymphocytes, a type of immune cell.
Period30 Apr 2020

Documents & Links